Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT

Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT - Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051430

Enrollment

100

Registered

2023-06-23

Start date

2023-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with diffuse liver disease 2) Patients with pathological conditions associated with portal hypertension and scheduled perfusion CT examination in routine practice for evaluation of treatment involving alteration of portal blood flow 3) Patients aged 20 years or older at the time of informed consent 4) Patients who have given written informed consent of their own free will after receiving sufficient explanation about participating in this study.

Exclusion criteria

Exclusion criteria: 1) Patients who are examined in routine clinical practice and who are judged by the principal investigator or sub-investigator to be inappropriate for conducting this study safely

Design outcomes

Primary

Measure	Time frame
Evaluation of changes in portal vein perfusion and arterial perfusion by perfusion CT	—

Countries

Japan

Contacts

Public ContactHidemi Unozawa

Chiba University Hospital Gastroenterology

unozawa.hidemi@chiba-u.jp0432227171

Outcome results